Sun Pharma to acquire Organon in a $12B deal, expanding global reach and strengthening its specialty drug portfolio.
Browsing: Pharmaceuticals
The Trump administration reclassifies medical marijuana, signaling policy change with major healthcare and industry implications.
Merck partners with Google Cloud to deploy AI in drug discovery, clinical trials, and manufacturing, signaling a major pharma shift.
Novo Nordisk partners with OpenAI to accelerate drug discovery using AI across research manufacturing and operations globally efforts
Middle East war disrupts pharma routes, threatening refrigerated cancer drug supplies to Gulf as hubs shut and shipments reroute.
Sanjay Kumar accused of selling tens of thousands of dollars’ worth of counterfeit cancer medication.
Tariffs fail to ensure resilience; Expothon promotes SME mobilization as the true engine of economic prosperity.
Gilead to acquire Arcellx for $7.8 billion, strengthening oncology pipeline with anito-cel CAR T-cell therapy.
FDA Commissioner Marty Makary says he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring
Hormones orchestrate everything from energy to cognition — so why does mainstream medicine ignore their decline, and sometimes accelerate it?
Trump launches TrumpRx.gov offering discounted prescription drugs for cash-paying patients, aiming to lower drug prices nationwide.
National Institutes of Health director Jay Bhattacharya says extensive studies show no link between vaccines, MMR shots, and autism.
Biopharmaceutical company AbbVie has reached an agreement with the Trump administration to invest $100 billion in its U.S. operations
Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally
Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.
India faces a sharp export decline to the U.S. as steep tariff hikes severely impact major sectors and trade performance.
Eli Lilly has become the first healthcare company to hit a $1 trillion market value, entering an exclusive club dominated by tech companies
Several pharmaceutical companies have said they will sell drugs directly to patients in the US and offer discounts
Novo Nordisk said Wednesday it has agreed to the U.S. Inflation Reduction Act’s (IRA) negotiated maximum fair prices for semaglutide
Pharma shares climbed up to 4% on Oct. 9 after a report said President Donald Trump isn’t planning to impose tariffs on generic drugs from foreign countries.
It looks like Johnson & Johnson will have to part with nearly a billion dollars. A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma
Rite Aid, one of America’s oldest pharmacy chains, has officially shut down after decades of service, following bankruptcy, opioid lawsuits, and mounting financial struggles.
Trump escalates tariffs on drugs, metals, trucks, and furniture under national security grounds, reshaping global trade while pressuring allies like India to navigate oil import challenges.
Eli Lilly will invest $6.5 billion to build a state-of-the-art biomanufacturing facility in Houston, creating 600 jobs and boosting production of advanced therapies.
A federal judge ordered the Trump administration to restore $500 million in UCLA medical research grants, safeguarding vital studies and reinforcing UC’s stance against political interference.